Risk factor
Strong trading liquidity
Profitability factor
Overvalued vs peers
About
Shenzhen Kangtai Biological Products Co., Ltd. researches, develops, produces, and sells various types of human vaccines in China. The company's products include cell-free whitebait b-type haemophilus influenzae combined vaccine, SARS-COV-2 vaccine, recombinant hepatitis B vaccine, 23-valent pneumococcal polysaccharide vaccine, diphtheria tetanus acellular pertussis and haemophilus influenzae type b combined vaccine, haemophilus influenzae type b conjugate...
Company Valuation
Considering past and projected metrics, the stock is 'expensive' compared to its peers. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBITDA, reasonably
Target Price
The average target price of 300601.SZ is 19 and suggests 28% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to inc
Buy
Sell